What is HYFT's current stock price?

HYFT (MindWalk Holdings Corp.) is currently trading at $1.71 with a market cap of $79.9M.

What sector is MindWalk Holdings Corp. in?

MindWalk Holdings Corp. (HYFT) operates in the Healthcare sector, specifically in the Biotechnology industry.

Is HYFT a good stock to buy?

Analysts have a Buy consensus on HYFT with a price target of $5.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

HYFT MindWalk Holdings Corp.

Healthcare

$1.71+11.04%ClosedMarket Cap: $79.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

7.33

P/S

6.01

EV/EBITDA

-9.41

DCF Value

$-6.12

FCF Yield

-10.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

60.3%

Operating Margin

-65.3%

Net Margin

-66.4%

ROE

-63.2%

ROA

-52.6%

ROIC

-63.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q3 null	$4.1M	$-3.9M	$—
Q2 null	$4.1M	$-3.2M	$—
Q1 null	$3.2M	$-3.0M	$—
Q4 null	$7.0M	$-2.2M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$5.00

Target (Median)

$5.00

Target Range

$5.00 - $5.00

0 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2026-05-19

Trading Activity

Insider Trades

View All

Aisling Capital II LP10 percent owner

SellMon Mar 03

Aisling Capital II LP10 percent owner

SellMon Mar 03

Aisling Capital II LP10 percent owner

SellMon Mar 03

Aisling Capital II LP10 percent owner

SellMon Mar 03

TULLIS DICKERSON CAPITAL FOCUS III, L.P.10 percent owner

SellFri Feb 29

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

0.65

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Peers